Diana Hughes

Senior Vice President, Global Patient Safety · Regeneron Pharmaceuticals

Biopharmaceuticals

Diana Hughes is senior vice president of global patient safety at Regeneron Pharmaceuticals. She joined in 2019 after pharmaceutical safety experience at Sunovion, FORUM and Pfizer and an earlier career as a medical practitioner.

Last reviewed: Oct 21, 2026

Diana Hughes

Senior Vice President, Global Patient Safety Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Diana Hughes is senior vice president of global patient safety at Regeneron Pharmaceuticals. She joined in 2019 after pharmaceutical safety experience at Sunovion, FORUM and Pfizer and an earlier career as a medical practitioner.

Career Highlights

  • Joined Regeneron in 2019.
  • Led the evolution of pharmacovigilance and risk management into Global Patient Safety.
  • Previously spent fourteen years at Pfizer.

Professional Journey

Hughes worked as a medical practitioner in the United Kingdom and United States before joining the pharmaceutical industry. Her subsequent career included fourteen years at Pfizer in positions of increasing responsibility, as well as work at Sunovion Pharmaceuticals and FORUM Pharmaceuticals.

She joined Regeneron in 2019. Under her leadership, the pharmacovigilance and risk management function evolved into Global Patient Safety. She reorganized the function to support the company’s global pipeline and align with the changing regulatory environment.

Her responsibilities integrate scientific safety work, operations and technology. The progression draws on both her clinical background and pharmaceutical industry experience.

Education

Hughes earned an MBBS from the Royal Free Hospital and School of Medicine, University of London, and an MSc from Hibernia College.